Walleye Capital’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-209
| Closed | -$22.4K | – | 2126 |
|
|
2024
Q4 | $22.4K | Sell |
209
-546
| -72% | -$58.5K | ﹤0.01% | 1841 |
|
|
2024
Q3 | $75.6K | Buy |
+755
| New | +$75.6K | ﹤0.01% | 1947 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 2829 |
|
|
2023
Q4 | – | Sell |
-2,469
| Closed | -$148K | – | 2619 |
|
|
2023
Q3 | $148K | Buy |
+2,469
| New | +$148K | ﹤0.01% | 1570 |
|
|
2023
Q2 | – | Sell |
-10,078
| Closed | -$741K | – | 2505 |
|
|
2023
Q1 | $741K | Sell |
10,078
-1,339
| -12% | -$98.5K | 0.01% | 835 |
|
|
2022
Q4 | $763K | Buy |
11,417
+5,540
| +94% | +$370K | 0.01% | 819 |
|
|
2022
Q3 | $316K | Sell |
5,877
-1,835
| -24% | -$98.7K | 0.01% | 1271 |
|
|
2022
Q2 | $429K | Buy |
+7,712
| New | +$429K | 0.01% | 1102 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 897 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 766 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 713 |
|